Andrew P. Han

Editor

Phone Number

+1-212-651-5640

Email

[email protected]

Andrew Han covers breaking news for GenomeWeb. He tracks companies in the sequencing and diagnostic markets.

Articles Authored by Andrew P. Han

May 29, 2020

Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering

Premium

The infectious disease testing firm has developed a sequencing-based coronavirus assay, which it plans to commercialize through its sister firm BioID Genomics.

May 13, 2020

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Premium

The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.

Mar 11, 2020

Fulgent Genetics Developing PCR, NGS Coronavirus Diagnostic Tests

Premium

Fulgent and its China-based joint venture  are  working on a clinical NGS-based  test that  it says will have better  sensitivity than RT-PCR-based kits.

Mar 05, 2020

New Sepsis Test Uses Nanopore Sequencing to Detect Pathogens From Cell-Free DNA

Premium

The method uses nanopore sequencing to analyze short cell-free DNA fragments from blood, providing results in as little as six hours.

Feb 27, 2020

Adaptive Biotechnologies ImmunoSeq Dx Development Jolts Forward With Lyme Disease in Crosshairs

Premium

The immune sequencing firm has engaged the FDA in discussions over how to get regulatory approval for one test for several seemingly different diseases.

Feb 07, 2020

Pacific Biosciences Targets China Clinical Market to Rebound After Illumina Deal Falls Through

Premium

PacBio will try to take the Sequel II to the clinic in China with the help of Berry Genomics and is open to partnerships globally, including with Illumina.

Jan 06, 2020

Nov 05, 2019

Fulgent Genetics Eyes 'Aggressive' Commercial Strategy

Premium

The firm is looking to expand its sales internationally, as well as in the consumer-initiated market, but is being conservative with revenue growth estimates.

Menu

Andrew P. Han

Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Fulgent Genetics Developing PCR, NGS Coronavirus Diagnostic Tests

New Sepsis Test Uses Nanopore Sequencing to Detect Pathogens From Cell-Free DNA

Adaptive Biotechnologies ImmunoSeq Dx Development Jolts Forward With Lyme Disease in Crosshairs

Pacific Biosciences Targets China Clinical Market to Rebound After Illumina Deal Falls Through

Guardant Health CEO Deleted Email Evidence After Lawsuit Deposition

NIH Awards $102.5M for Antibacterial Resistance Research, Dx Development

Agilent's Magnis Joins Set-and-Forget Movement in Library Prep Instruments

Fulgent Genetics Eyes 'Aggressive' Commercial Strategy

Breaking News

FDA Issues Emergency Use Authorization for University of Nebraska Medical Center Coronavirus Test

Oxford Immunotec Shares Rise Sharply on Report of $400M Acquisition Offer

Medix Biochemica Acquires US Firms EastCoast Bio, Biostride

HHS Releases Data Reporting Guidance for Labs Performing SARS-CoV-2 Testing

Opti Medical Systems Gets CE Mark for Coronavirus Test Kit

AACC Revises Guidance on Management of Point-of-Care Testing

Sponsorships